BNT321

BNT321 · BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT321, covering 2025-10-31 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma [Phase 1, Phase 2]

See pricing